Data / Form D filings / Adela, Inc.
Adela, Inc.: Form D filing
Adela, Inc., a biotechnology company in Foster City, CA, filed a Form D with the SEC in 2026. The latest, on October 19, 2026, reports $12 million sold of a $12 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 353 HATCH DRIVE, Foster City, CA, 94404
- Phone
- (888) 210-1773
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1852167
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 19 | New notice | $12,000,000 | $12,000,000 | 5 | Oct 2 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lindsay Mateo | Executive Officer, Director | |
| David Bonita | Director | |
| Paul Brown | Director | |
| Daniel Diniz De Carvalho | Executive Officer | |
| Anne-Renee Hartman | Executive Officer | |
| Maneesh Jain | Director | |
| David Scheer | Executive Officer, Director | |
| Robert Weisskoff | Director | |
| Alan Williams | Executive Officer | |
| Abraham Kometz | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $22.9 million · Oct 21
- Theravie Pharma, Inc. $750,000 · Oct 19
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16
- Renue Life Sciences, Inc. $250,000 · Oct 14
- Tempest Therapeutics, Inc. $7.5 million · Oct 14
- Lionheart Health, Inc. $387,500 · Oct 7
Every Form D from the week of Oct 19 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Adela, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.